AKUA AMPONSAH-ADJEI: Open Payments
NPI 1821719469 · STAFFORD, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$692 in 24 payments from 8 companies in 2025. Trend: 2023 $110 · 2024 $392 · 2025 $692
Food & beverage: $692
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 9 | $252 |
| E.R. Squibb & Sons, L.L.C. | 4 | $182 |
| Lundbeck LLC | 3 | $76 |
| ABBVIE INC. | 3 | $69 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| Supernus Pharmaceuticals, Inc. | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $15 |
Products named: REXULTI, COBENFY, VRAYLAR, CAPLYTA, TRINTELLIX, Qelbree, Auvelity.
Industry payments across VA — which companies pay providers there.
